Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration
Therapeutic Advances in Drug Safety · 2025-12 · 16
DOI: 10.1177/20420986251361435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Drug Safety, online erschienen am 31.07.2025. Verfasst von Ankit Nagar und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland Baltimore, Rm S41020 N Pine St, Baltimore, MD 21201, USA. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Artificial intelligence (AI) has rapidly evolved from experimental applications in pharmacovigilance (PV) to being considered for routine use. This review critically examines AI’s potential to revolutionize drug safety monitoring, focusing on practical implementation challenges such as ensuring AI’s consistent and transparent performance, reducing multiple sources of bias, and addressing interpretability issues. It emphasizes the transition from experimental use to a routine, scalable capability within PV. It examines AI’s evidence base in specific applications, its ability to enhance actionable insights, and how organizations can safeguard against unintended consequences in multi-AI system environments. These considerations are vital as AI moves from theory to practice in PV.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Maryland Baltimore, Rm S41020 N Pine St, Baltimore, MD 21201, USA.
- Department of Practice, Science, and Health Outcomes Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
- Pfizer Inc., New York, NY, USA.
ORCID-Profile: Ankit Nagar
Zitieren
APA
Nagar, A., Gobburu, J., & Chakravarty, A. (2025). Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration. Therapeutic Advances in Drug Safety, 16. https://doi.org/10.1177/20420986251361435
Vancouver
Nagar A, Gobburu J, Chakravarty A. Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration. Therapeutic Advances in Drug Safety. 2025;16. doi:10.1177/20420986251361435
BibTeX
@article{Nagar2025,
author = {Nagar, Ankit and Gobburu, Joga and Chakravarty, Aloka},
title = {Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration},
journal = {Therapeutic Advances in Drug Safety},
year = {2025},
volume = {16},
doi = {10.1177/20420986251361435}
}
EUVIMED